ES2897983T8 - Liposomas cargados con IPA-3 y procedimientos de uso de los mismos - Google Patents

Liposomas cargados con IPA-3 y procedimientos de uso de los mismos

Info

Publication number
ES2897983T8
ES2897983T8 ES17753707T ES17753707T ES2897983T8 ES 2897983 T8 ES2897983 T8 ES 2897983T8 ES 17753707 T ES17753707 T ES 17753707T ES 17753707 T ES17753707 T ES 17753707T ES 2897983 T8 ES2897983 T8 ES 2897983T8
Authority
ES
Spain
Prior art keywords
ipa
methods
liposomes loaded
liposomes
loaded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17753707T
Other languages
English (en)
Other versions
ES2897983T3 (es
Inventor
Somanath Rammohan Shenoy
Brian S Cummings
Wided Najahi Missaoui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia, University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia
Application granted granted Critical
Publication of ES2897983T3 publication Critical patent/ES2897983T3/es
Publication of ES2897983T8 publication Critical patent/ES2897983T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ES17753707T 2016-02-15 2017-02-14 Liposomas cargados con IPA-3 y procedimientos de uso de los mismos Active ES2897983T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662295331P 2016-02-15 2016-02-15
PCT/US2017/017828 WO2017142876A1 (en) 2016-02-15 2017-02-14 lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF

Publications (2)

Publication Number Publication Date
ES2897983T3 ES2897983T3 (es) 2022-03-03
ES2897983T8 true ES2897983T8 (es) 2022-05-24

Family

ID=59626317

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17753707T Active ES2897983T3 (es) 2016-02-15 2017-02-14 Liposomas cargados con IPA-3 y procedimientos de uso de los mismos

Country Status (4)

Country Link
US (1) US11517539B2 (es)
EP (1) EP3416623B1 (es)
ES (1) ES2897983T3 (es)
WO (1) WO2017142876A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220211621A1 (en) * 2019-04-25 2022-07-07 Tlc Biopharmaceuticals, Inc. Liposomal sustained-release compositions containing a therapeutic drug and use thereof
WO2021072407A1 (en) * 2019-10-10 2021-04-15 The University Of North Carolina At Chapel Hill Delivery system complexes comprising a precipitate of an active agent and methods of use
GB202112471D0 (en) 2021-09-01 2021-10-13 King S College London Microna systems
TW202345843A (zh) * 2022-04-06 2023-12-01 財團法人國家衛生研究院 脂質奈米顆粒及脂質體

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20040102623A1 (en) 2002-11-23 2004-05-27 Isis Pharmaceuticals Inc. Modulation of PAK1 expression
KR101462825B1 (ko) * 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
US20080097062A1 (en) 2005-02-09 2008-04-24 Albemarle Corporation Method of Producing Disproportionated Rosin
CA2680606C (en) 2006-03-29 2014-08-05 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
EP2136788B1 (en) 2007-03-30 2011-10-26 Bind Biosciences, Inc. Cancer cell targeting using nanoparticles
EP2504011A4 (en) 2009-11-23 2013-07-31 Afraxis Inc METHOD FOR TREATING EASY COGNITIVE IMPAIRMENT
RU2013126036A (ru) 2010-11-17 2014-12-27 Ф. Хоффманн-Ля Рош Аг Способ лечения опухолей
EP2683410A2 (en) * 2011-03-08 2014-01-15 Access Pharmaceuticals, Inc. Targeted nanocarrier systems for delivery of actives across biological membranes
US8771682B2 (en) 2011-04-26 2014-07-08 Technische Universtität Dresden Methods and compositions for reducing interleukin-4 or interleukin-13 signaling
WO2012167028A2 (en) * 2011-06-02 2012-12-06 The Regents Of The University Of California Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
US9011903B2 (en) 2011-06-08 2015-04-21 Nitto Denko Corporation Cationic lipids for therapeutic agent delivery formulations
PL3419289T3 (pl) 2011-06-30 2021-04-19 JVC Kenwood Corporation Urządzenie do dekodowania obrazu, sposób dekodowania obrazu i program do dekodowania obrazu
EP2773426B1 (en) 2011-10-31 2018-08-22 Mallinckrodt LLC Combinational liposome compositions for cancer therapy
JP6427097B2 (ja) 2012-06-15 2018-11-21 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 癌を処置するための組成物および該組成物を製造するための方法
MX2015012199A (es) 2013-03-13 2015-11-30 Mallinckrodt Llc Composiciones de cisplatino liposomal para la terapia contra el cancer.
KR102205278B1 (ko) 2013-03-14 2021-01-22 다이서나 파마수이티컬, 인크. 음이온성 약제를 제형화하는 방법
WO2014150790A1 (en) 2013-03-15 2014-09-25 Albert Einstein College Of Medicine Of Yeshiva University Pak1 inhibition for treatment of acute myeloid leukemia and myelodysplastic syndromes
US9861625B2 (en) 2014-01-08 2018-01-09 Duke University Methods and compositions for treating cancer through inhibition of PI3K
US10258629B2 (en) 2014-03-28 2019-04-16 The Regents Of The University Of California Liposomal drug encapsulation
AU2015241198A1 (en) 2014-04-03 2016-11-17 Invictus Oncology Pvt. Ltd. Supramolecular combinatorial therapeutics
CN114642735A (zh) 2015-01-21 2022-06-21 菲泽尔克斯公司 用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统
US11045554B1 (en) 2018-06-22 2021-06-29 National Technology & Engineering Solutions Of Sandia, Llc Lipid-coated particles for treating viral infections

Also Published As

Publication number Publication date
EP3416623A4 (en) 2019-10-30
ES2897983T3 (es) 2022-03-03
US20230110087A1 (en) 2023-04-13
EP3416623B1 (en) 2021-08-11
US11517539B2 (en) 2022-12-06
US20210186894A1 (en) 2021-06-24
WO2017142876A1 (en) 2017-08-24
EP3416623A1 (en) 2018-12-26

Similar Documents

Publication Publication Date Title
IL292094A (en) Neoantigens and methods for using them
DOP2021000112A (es) Compuestos de pirrolizina sustituida y usos de los mismos
CL2019002503A1 (es) Compuesto de sulfamida cíclico y métodos de uso de los mismo.
CL2018000708A1 (es) Fitasas modificadas y métodos de uso
CL2016001868A1 (es) Proteinas de union y sus métodos de uso
CL2017003486A1 (es) Lactamas bicíclicas y métodos de uso de las mismas
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
CL2016002364A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas
CL2016002252A1 (es) Anticuerpos anti-egfrviii y usos de los mismos
IL255801A (en) Liposomal nanoconstructs and methods of making and using the same
CL2018001139A1 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos.
ES2966692T3 (es) Vectores de virus adenoasociados poliploides y métodos de fabricación y uso de los mismos
FI20145195A (fi) Eutektiset liuotinseokset ja niiden käyttö
CL2015003406A1 (es) Anticuerpos receptores de antitransferina y métodos de uso campo de la invención
CL2015003441A1 (es) Composiciones de arní de serpina1 y sus métodos de uso
BR112016024034A2 (pt) ativadores de canal iônico e métodos de uso
BR112018000129A2 (pt) oxiesteróis e seus métodos de utilização
FI20145087A (fi) Parannettu gyroskooppirakenne ja gyroskooppi
CL2016001432A1 (es) Nuevos anticuerpos anti-dpep3 y métodos de uso
BR112017004648A2 (pt) simuladores mir-29 e os usos deste
BR112016020889A2 (pt) variantes de hppd e métodos de uso
BR112016006614A2 (pt) composições de trichoderma e métodos de uso
CL2016000235A1 (es) Inhibidores de rorc2 y sus métodos de uso
FI20155153A (fi) Mikroelektromekaaninen rakenne ja laite
ES2897983T8 (es) Liposomas cargados con IPA-3 y procedimientos de uso de los mismos